Voyageur Pharmaceuticals Ltd (VM) — Capital Reinvestment Ratio

Latest as of November 2023: 1.12x

Voyageur Pharmaceuticals Ltd (VM) has a Capital Reinvestment Ratio of 1.12x as of November 2023, meaning it reinvests 1% of its operating cash flow (CA$29.56K) in capital expenditures (CA$33.21K). Check VM tangible net assets ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

1.12x

Capex / Operating Cash Flow

Operating Cash Flow

CA$29.56K

CAD

Capital Expenditures

CA$33.21K

CAD

Data as of

Nov 2023

Most recent filing

Annual Capital Reinvestment Ratio for Voyageur Pharmaceuticals Ltd (None–None)

Year-by-year Capital Reinvestment Ratio for Voyageur Pharmaceuticals Ltd from None to None. See free cash flow generation of Voyageur Pharmaceuticals Ltd to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (CAD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow